Cynomolgus BCMA/TNFRSF17 Protein, Accession: A0A2K5UD97

/在： /经由过程：
  • 产物概述
  • 产物规格
  • 运输及存储
  • 品牌申明

    • 产物概述

    产物描写

    Recombinant Cynomolgus BCMA/TNFRSF17 Protein is expressed from HEK293 with hFc at the C-terminal.It contains Met1-Ala53.

    Biotinylated

    产物规格

    靶点

    BCMA/TNFRSF17

    份子又名

    CD269; TNFRSF17; BCMA; BCM; TNFRSF13A

    Accession

    种属

    Cynomolgus

    卵白序列

    Met1-Ala53

    份子量

    The protein has a predicted MW of 31.5 kDa. Due to glycosylation, the protein migrates to 35-45 kDa based on Tris-Bis PAGE result.

    活性

    Immobilized Cynomolgus BCMA, hFc Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Anti-BCMA Antibody, hFc Tag with the EC50 of 3.4ng/ml determined by ELISA. See testing image for detail.

    产物标签

    C-hFc

    抒发体系

    HEK293

    纯度

    > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC

    内毒素

    Less than 1EU per ug by the LAL method.

    运输及存储

    产物表面

    Lyophilized

    运输前提

    Shipped at ambient temperature.

    制剂

    Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

    复溶

    Centrifuge tubes before opening. Reconstituting to a concentration more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water.

    存储和不变性

    Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 该有机物的项目ChemWhat是Watson的登记类型，由Watson受权宁波海角社区 在中国国家国内地区性合理利用，.